The· Nikkei 225 The index fell 0.96% to 28,546.18 points, led by consumer circulation, energy and material manufacturers. The broader Topix decreased 0.75% to 1,848.00.
The United States had a hard time getting up vaccinationEuropean countries are facing delays from their suppliers, and Japan has not yet begun vaccination, putting pressure on investor sentiment.
In addition, Merck & Co Inc has terminated the development of the Covid-19 vaccine and has expressed further concern about the supply shortage.
Japan’s stock price jumped to its 30-year high last week, but this week there are busy earnings calendars in the US and Japan. Federal Reserve The meeting, which ends on Wednesday, encourages investors to make a profit.
Norihiro Fujito, chief investment strategist at Mitsubishi UFJ Morgan Stanley Securities, said, “There is new concern that the coronavirus will exist longer than expected, which explains the decline in circulating stocks and the increase in defense stocks. I have. ”
According to some analysts, some of the Bank of Japan’s policy makers called for more flexible purchases of exchange-traded funds. This could manifest itself as another negative factor for equities when the central bank reviewed its policies in March.
Daikin Industries, Ltd.’s top-ranked performance slump decreased by 2.98%, followed by Topix 30. Toyota Motor Lose 2.31%.
Takeda Pharmaceutical Company rose 1.83% and KDDI rose 1.23%.
The Nikkei Stock Average had 157 downs and 80 ups.
Amount of shares traded in Tokyo Stock ExchangeMainboards were 930 million, compared to an average of 1.12 billion over the last 30 days.
Japanese stocks fall due to vaccine delays, caution ahead of earnings season
https://economictimes.indiatimes.com/markets/stocks/news/japan-shares-end-lower-on-vaccine-delay-caution-ahead-of-earnings-season/articleshow/80463556.cms Japanese stocks fall due to vaccine delays, caution ahead of earnings season